Reviews Teriparatide


No reviews yet.

Forteo Drug Description
FORTEO
(teriparatide [rDNA origin]) Injection for Subcutaneous use

WARNING
POTENTIAL RISK OF OSTEOSARCOMA
In male and female rats, teriparatide caused an increase in the incidence
of osteosarcoma (a malignant bone tumor) that  was dependent on dose and treatment
duration. The effect was observed at systemic exposures to teriparatide ranging
from 3 to 60 times the exposure in humans given a 20-mcg dose. Because of
the uncertain relevance of the rat osteosarcoma finding to humans, prescribe
FORTEO® only for patients for whom the potential benefits are considered
to outweigh the potential risk. FORTEO should not be prescribed for patients
who are at increased baseline risk for osteosarcoma (including those with
Paget's disease of bone or unexplained elevations of alkaline phosphatase,
pediatric and young adult patients with open epiphyses, or prior external
beam or implant radiation therapy involving the skeleton) [see WARNINGS AND
PRECAUTIONS, ADVERSE REACTIONS,
and Nonclinical Toxicology].

DRUG DESCRIPTION



What are the possible side effects of teriparatide (Forteo)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using teriparatide and call your doctor at once if you have any of these serious side effects:

feeling light-headed or fainting every time you inject this medicine;
fast or pounding heartbeats every time you inject this medicine; or
nausea, vomiting, constipation, and muscle weakness.

Less...
Read All Potential Side Effects for Forteo »




FORTEO (teriparatide [rDNA origin] injection) contains
recombinant human parathyroid hormone (1-34), and is also called rhPTH (1-34).
It has an identical sequence to the 34 N-terminal amino acids (the biologically
active region) of the 84-amino acid human parathyroid hormone.
Teriparatide has a molecular weight of 4117.8 daltons and
its amino acid sequence is shown below:









Teriparatide (rDNA origin) is manufactured using a strain of
Escherichia coli modified by recombinant DNA technology. FORTEO is
supplied as a sterile, colorless, clear, isotonic solution in a glass cartridge
which is pre-assembled into a disposable delivery device (pen) for subcutaneous
injection. Each prefilled delivery device is filled with either 3.3 mL to
deliver 3 mL or 2.7 mL to deliver 2.4 mL. Each mL contains 250 mcg teriparatide
(corrected for acetate, chloride, and water content), 0.41 mg glacial acetic
acid, 0.1 mg sodium acetate (anhydrous), 45.4 mg mannitol, 3 mg Metacresol, and
Water for Injection. In addition, hydrochloric acid solution 10% and/or sodium
hydroxide solution 10% may have been added to adjust the product to pH 4.
Each cartridge, pre-assembled into a delivery device,
delivers 20 mcg of teriparatide per dose each day for up to 28 days.
Last reviewed on RxList: 8/10/2009




Forteo Drug Description
FORTEO
(teriparatide [rDNA origin]) Injection for Subcutaneous use

WARNING
POTENTIAL RISK OF OSTEOSARCOMA
In male and female rats, teriparatide caused an increase in the incidence
of osteosarcoma (a malignant bone tumor) that  was dependent on dose and treatment
duration. The effect was observed at systemic exposures to teriparatide ranging
from 3 to 60 times the exposure in humans given a 20-mcg dose. Because of
the uncertain relevance of the rat osteosarcoma finding to humans, prescribe
FORTEO® only for patients for whom the potential benefits are considered
to outweigh the potential risk. FORTEO should not be prescribed for patients
who are at increased baseline risk for osteosarcoma (including those with
Paget's disease of bone or unexplained elevations of alkaline phosphatase,
pediatric and young adult patients with open epiphyses, or prior external
beam or implant radiation therapy involving the skeleton) [see WARNINGS AND
PRECAUTIONS, ADVERSE REACTIONS,
and Nonclinical Toxicology].

DRUG DESCRIPTION



What are the possible side effects of teriparatide (Forteo)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using teriparatide and call your doctor at once if you have any of these serious side effects:

feeling light-headed or fainting every time you inject this medicine;
fast or pounding heartbeats every time you inject this medicine; or
nausea, vomiting, constipation, and muscle weakness.

Less...
Read All Potential Side Effects for Forteo »




FORTEO (teriparatide [rDNA origin] injection) contains
recombinant human parathyroid hormone (1-34), and is also called rhPTH (1-34).
It has an identical sequence to the 34 N-terminal amino acids (the biologically
active region) of the 84-amino acid human parathyroid hormone.
Teriparatide has a molecular weight of 4117.8 daltons and
its amino acid sequence is shown below:









Teriparatide (rDNA origin) is manufactured using a strain of
Escherichia coli modified by recombinant DNA technology. FORTEO is
supplied as a sterile, colorless, clear, isotonic solution in a glass cartridge
which is pre-assembled into a disposable delivery device (pen) for subcutaneous
injection. Each prefilled delivery device is filled with either 3.3 mL to
deliver 3 mL or 2.7 mL to deliver 2.4 mL. Each mL contains 250 mcg teriparatide
(corrected for acetate, chloride, and water content), 0.41 mg glacial acetic
acid, 0.1 mg sodium acetate (anhydrous), 45.4 mg mannitol, 3 mg Metacresol, and
Water for Injection. In addition, hydrochloric acid solution 10% and/or sodium
hydroxide solution 10% may have been added to adjust the product to pH 4.
Each cartridge, pre-assembled into a delivery device,
delivers 20 mcg of teriparatide per dose each day for up to 28 days.
Last reviewed on RxList: 8/10/2009




Forteo Drug Description
FORTEO
(teriparatide [rDNA origin]) Injection for Subcutaneous use

WARNING
POTENTIAL RISK OF OSTEOSARCOMA
In male and female rats, teriparatide caused an increase in the incidence
of osteosarcoma (a malignant bone tumor) that  was dependent on dose and treatment
duration. The effect was observed at systemic exposures to teriparatide ranging
from 3 to 60 times the exposure in humans given a 20-mcg dose. Because of
the uncertain relevance of the rat osteosarcoma finding to humans, prescribe
FORTEO® only for patients for whom the potential benefits are considered
to outweigh the potential risk. FORTEO should not be prescribed for patients
who are at increased baseline risk for osteosarcoma (including those with
Paget's disease of bone or unexplained elevations of alkaline phosphatase,
pediatric and young adult patients with open epiphyses, or prior external
beam or implant radiation therapy involving the skeleton) [see WARNINGS AND
PRECAUTIONS, ADVERSE REACTIONS,
and Nonclinical Toxicology].

DRUG DESCRIPTION



What are the possible side effects of teriparatide (Forteo)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using teriparatide and call your doctor at once if you have any of these serious side effects:

feeling light-headed or fainting every time you inject this medicine;
fast or pounding heartbeats every time you inject this medicine; or
nausea, vomiting, constipation, and muscle weakness.

Less...
Read All Potential Side Effects for Forteo »




FORTEO (teriparatide [rDNA origin] injection) contains
recombinant human parathyroid hormone (1-34), and is also called rhPTH (1-34).
It has an identical sequence to the 34 N-terminal amino acids (the biologically
active region) of the 84-amino acid human parathyroid hormone.
Teriparatide has a molecular weight of 4117.8 daltons and
its amino acid sequence is shown below:









Teriparatide (rDNA origin) is manufactured using a strain of
Escherichia coli modified by recombinant DNA technology. FORTEO is
supplied as a sterile, colorless, clear, isotonic solution in a glass cartridge
which is pre-assembled into a disposable delivery device (pen) for subcutaneous
injection. Each prefilled delivery device is filled with either 3.3 mL to
deliver 3 mL or 2.7 mL to deliver 2.4 mL. Each mL contains 250 mcg teriparatide
(corrected for acetate, chloride, and water content), 0.41 mg glacial acetic
acid, 0.1 mg sodium acetate (anhydrous), 45.4 mg mannitol, 3 mg Metacresol, and
Water for Injection. In addition, hydrochloric acid solution 10% and/or sodium
hydroxide solution 10% may have been added to adjust the product to pH 4.
Each cartridge, pre-assembled into a delivery device,
delivers 20 mcg of teriparatide per dose each day for up to 28 days.
Last reviewed on RxList: 8/10/2009




Forteo Drug Description
FORTEO
(teriparatide [rDNA origin]) Injection for Subcutaneous use

WARNING
POTENTIAL RISK OF OSTEOSARCOMA
In male and female rats, teriparatide caused an increase in the incidence
of osteosarcoma (a malignant bone tumor) that  was dependent on dose and treatment
duration. The effect was observed at systemic exposures to teriparatide ranging
from 3 to 60 times the exposure in humans given a 20-mcg dose. Because of
the uncertain relevance of the rat osteosarcoma finding to humans, prescribe
FORTEO® only for patients for whom the potential benefits are considered
to outweigh the potential risk. FORTEO should not be prescribed for patients
who are at increased baseline risk for osteosarcoma (including those with
Paget's disease of bone or unexplained elevations of alkaline phosphatase,
pediatric and young adult patients with open epiphyses, or prior external
beam or implant radiation therapy involving the skeleton) [see WARNINGS AND
PRECAUTIONS, ADVERSE REACTIONS,
and Nonclinical Toxicology].

DRUG DESCRIPTION



What are the possible side effects of teriparatide (Forteo)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using teriparatide and call your doctor at once if you have any of these serious side effects:

feeling light-headed or fainting every time you inject this medicine;
fast or pounding heartbeats every time you inject this medicine; or
nausea, vomiting, constipation, and muscle weakness.

Less...
Read All Potential Side Effects for Forteo »




FORTEO (teriparatide [rDNA origin] injection) contains
recombinant human parathyroid hormone (1-34), and is also called rhPTH (1-34).
It has an identical sequence to the 34 N-terminal amino acids (the biologically
active region) of the 84-amino acid human parathyroid hormone.
Teriparatide has a molecular weight of 4117.8 daltons and
its amino acid sequence is shown below:









Teriparatide (rDNA origin) is manufactured using a strain of
Escherichia coli modified by recombinant DNA technology. FORTEO is
supplied as a sterile, colorless, clear, isotonic solution in a glass cartridge
which is pre-assembled into a disposable delivery device (pen) for subcutaneous
injection. Each prefilled delivery device is filled with either 3.3 mL to
deliver 3 mL or 2.7 mL to deliver 2.4 mL. Each mL contains 250 mcg teriparatide
(corrected for acetate, chloride, and water content), 0.41 mg glacial acetic
acid, 0.1 mg sodium acetate (anhydrous), 45.4 mg mannitol, 3 mg Metacresol, and
Water for Injection. In addition, hydrochloric acid solution 10% and/or sodium
hydroxide solution 10% may have been added to adjust the product to pH 4.
Each cartridge, pre-assembled into a delivery device,
delivers 20 mcg of teriparatide per dose each day for up to 28 days.
Last reviewed on RxList: 8/10/2009




Forteo Drug Description
FORTEO
(teriparatide [rDNA origin]) Injection for Subcutaneous use

WARNING
POTENTIAL RISK OF OSTEOSARCOMA
In male and female rats, teriparatide caused an increase in the incidence
of osteosarcoma (a malignant bone tumor) that  was dependent on dose and treatment
duration. The effect was observed at systemic exposures to teriparatide ranging
from 3 to 60 times the exposure in humans given a 20-mcg dose. Because of
the uncertain relevance of the rat osteosarcoma finding to humans, prescribe
FORTEO® only for patients for whom the potential benefits are considered
to outweigh the potential risk. FORTEO should not be prescribed for patients
who are at increased baseline risk for osteosarcoma (including those with
Paget's disease of bone or unexplained elevations of alkaline phosphatase,
pediatric and young adult patients with open epiphyses, or prior external
beam or implant radiation therapy involving the skeleton) [see WARNINGS AND
PRECAUTIONS, ADVERSE REACTIONS,
and Nonclinical Toxicology].

DRUG DESCRIPTION



What are the possible side effects of teriparatide (Forteo)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using teriparatide and call your doctor at once if you have any of these serious side effects:

feeling light-headed or fainting every time you inject this medicine;
fast or pounding heartbeats every time you inject this medicine; or
nausea, vomiting, constipation, and muscle weakness.

Less...
Read All Potential Side Effects for Forteo »




FORTEO (teriparatide [rDNA origin] injection) contains
recombinant human parathyroid hormone (1-34), and is also called rhPTH (1-34).
It has an identical sequence to the 34 N-terminal amino acids (the biologically
active region) of the 84-amino acid human parathyroid hormone.
Teriparatide has a molecular weight of 4117.8 daltons and
its amino acid sequence is shown below:









Teriparatide (rDNA origin) is manufactured using a strain of
Escherichia coli modified by recombinant DNA technology. FORTEO is
supplied as a sterile, colorless, clear, isotonic solution in a glass cartridge
which is pre-assembled into a disposable delivery device (pen) for subcutaneous
injection. Each prefilled delivery device is filled with either 3.3 mL to
deliver 3 mL or 2.7 mL to deliver 2.4 mL. Each mL contains 250 mcg teriparatide
(corrected for acetate, chloride, and water content), 0.41 mg glacial acetic
acid, 0.1 mg sodium acetate (anhydrous), 45.4 mg mannitol, 3 mg Metacresol, and
Water for Injection. In addition, hydrochloric acid solution 10% and/or sodium
hydroxide solution 10% may have been added to adjust the product to pH 4.
Each cartridge, pre-assembled into a delivery device,
delivers 20 mcg of teriparatide per dose each day for up to 28 days.
Last reviewed on RxList: 8/10/2009





Other reviews about Teriparatide on wordpress

Teriparatide y alendronato en osteoporosis por corticoides
  by Ruben Roa
Background Bisphosphonate therapy is the current standard of care for the prevention and treatment of glucocorticoid-induced osteoporosis. Studies of anabolic therapy in patients who are […]


New England Journal of Medicine
  by Ruben Roa
Volume 357 — November 29, 2007 — Number 22   Rosuvastatin in Older Patients with Systolic Heart Failure Patent Foramen Ovale and Cryptogenic Stroke in Older Patients Late-Life […]


New England Journal of Medicine Nov 25, 2007. Num. 20
  by klod82
Volume 357 — November 15, 2007 — Number 20 The Anatomy of Medical School Patenting.pdf Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis.pdf Harlequin's Darker Side.pdf Diverticulitis.pdf Cetuximab […]


Boniva did not work for me - is forteo ok?
  by healtherm2
Question: I have osteoporosis in my spine and osteopenia in my hips. Iwas on Boniva for almost 2 years and my scores got worse. My dr. says […]


Boniva did not work for me - is forteo ok?
  by healtherm2
Question: I have osteoporosis in my spine and osteopenia in my hips. Iwas on Boniva for almost 2 years and my scores got worse. My dr. says […]


Miracle jab that heals bones twice as fast will revolutionise treatment, say doctors | Mail Online
  by David Granovsky
Doctors hail 'miracle jab' that will heal adult's bones as fast as children's By Fiona Macrae Last updated at 4:22 PM on 14th April 2009 A 'miracle' jab that spurs adults' […]


Slow-Healing Bones May Get Boost From Drug
  by timeinctemp
TUESDAY, April 14 (HealthDay News) — A drug that boosts the body's production of stem cells appears to "jump-start" the bone-healing process to a point that older adults' […]


Forteo Approved for Drug-Related Osteoporosis
  by timeinctemp
FRIDAY, July 24 (HealthDay News) — Eli Lilly's Forteo (teriparatide injection) has received expanded approval from the U.S. Food and Drug Administration to treat osteoporosis associated with long-term […]


9th December 2009
  by bfwlibrary
GO BACK TO MAIN LIBRARY NEWSLETTER GO BACK TO THE LIBRARY HOMEPAGE    The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review  To assess the […]



Other reviews about Teriparatide on web:

Teriparatide (Fosteo) is a recombinant human PTH1-34. ... Teriparatide (trade name Forteo) is a medication to treat osteoporosis that works in a different way than other ... Teriparatide - treats osteoporosis by first drug to cause new bone ...


Teriparatide (Forteo) is a recombinant form of parathyroid hormone, used in the treatment of some forms of osteoporosis It is manufactured and marketed by Eli Lilly and Company. Teriparatide - Wikipedia, the free encyclopedia


Consumer information about the medication TERIPARATIDE - INJECTION (Forteo), includes side effects, drug interactions, recommended dosages, and storage information. Read more ... TERIPARATIDE - INJECTION (Forteo) side effects, medical uses, and ...


Teriparatide Brand names: Forteo™ Chemical formula: Español: Teriparatida, Solución para inyección Teriparatide Solution for injection What is Teriparatide: Information from Answers.com


The most common side effects are dizziness, nausea, heartburn, diarrhea, headache and leg cramps, pain, weakness, and depression. Side Effects of Teriparatide | Side Effects of Forteo


All about Teriparatide. View complete and up to date Teriparatide information - part of the Drugs.com trusted medication database. Teriparatide Facts and Comparisons at Drugs.com


Physician reviewed teriparatide patient information - includes teriparatide description, dosage and directions. teriparatide medical facts from Drugs.com


Mayo Clinic offers award-winning medical and health information and tools for healthy living. Teriparatide (Subcutaneous Route) - MayoClinic.com


Features information about dosage, usage, warnings, and side effects. Teriparatide (rDNA origin) Injection: MedlinePlus Drug Information


: Where in the scheme of osteoporosis management does treatment with teriparatide fit? When to Use Teriparatide





Featured Reviews

Reviews Sermorelin Acetate

Sermorelin Acetate Drug Description Sermorelin Acetate (generic formulation) DRUG DESCRIPTION Sermorelin acetate is the acetate salt of an amidated synthetic 29- amino acid peptide (GRF 1-29 NH 2 ) that corresponds to the amino-terminal...
Read More  |  Review This
Reviews Alprostadil Dual Chamber System for Injection

Caverject Impulse Drug Description CAVERJECT IMPULSE Dual Chamber System (alprostadil) for Injection For Intracavernosal Use DRUG DESCRIPTION What are the possible side effects of alprostadil (Caverject, Caverject Impulse, Edex,...
Read More  |  Review This
Reviews Tripedia

Tripedia Drug Description Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia® DRUG DESCRIPTION What are the possible side effects of diphtheria, tetanus, and pertussis vaccines (Acel-Imune, Certiva,...
Read More  |  Review This
Reviews Hydroxyurea Capsules

Droxia Drug Description DROXIA® (hydroxyurea) Capsules, USP WARNING Treatment of patients with DROXIA may be complicated by severe, sometimes life-threatening, adverse effects. DROXIA should be administered under the supervision...
Read More  |  Review This
Reviews Azasan

Azasan Drug Description AZASAN® (azathioprine) 75 mg, 100 mg Scored Tablets , USP WARNING Chronic immunosuppression with this purine antimetabolite increases risk of neoplasia in humans. Physicians using this drug should be very...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....